241 related articles for article (PubMed ID: 31855437)
1. Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide.
Svoronos AA; Bahal R; Pereira MC; Barrera FN; Deacon JC; Bosenberg M; DiMaio D; Glazer PM; Engelman DM
Mol Pharm; 2020 Feb; 17(2):461-471. PubMed ID: 31855437
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic modeling reveals parameters that govern tumor targeting and delivery by a pH-Low Insertion Peptide (pHLIP).
Svoronos AA; Engelman DM
Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443162
[TBL] [Abstract][Full Text] [Related]
3. Targeting acidity in diseased tissues: mechanism and applications of the membrane-inserting peptide, pHLIP.
Deacon JC; Engelman DM; Barrera FN
Arch Biochem Biophys; 2015 Jan; 565():40-8. PubMed ID: 25444855
[TBL] [Abstract][Full Text] [Related]
4. Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors.
Wyatt LC; Moshnikova A; Crawford T; Engelman DM; Andreev OA; Reshetnyak YK
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2811-E2818. PubMed ID: 29507241
[TBL] [Abstract][Full Text] [Related]
5. Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation.
Kaplan AR; Pham H; Liu Y; Oyaghire S; Bahal R; Engelman DM; Glazer PM
Mol Cancer Res; 2020 Jun; 18(6):873-882. PubMed ID: 32098827
[TBL] [Abstract][Full Text] [Related]
6. pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents.
Andreev OA; Engelman DM; Reshetnyak YK
Mol Membr Biol; 2010 Oct; 27(7):341-52. PubMed ID: 20939768
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the pHLIP transmembrane helix insertion pathway.
Karabadzhak AG; Weerakkody D; Wijesinghe D; Thakur MS; Engelman DM; Andreev OA; Markin VS; Reshetnyak YK
Biophys J; 2012 Apr; 102(8):1846-55. PubMed ID: 22768940
[TBL] [Abstract][Full Text] [Related]
8. Roles of carboxyl groups in the transmembrane insertion of peptides.
Barrera FN; Weerakkody D; Anderson M; Andreev OA; Reshetnyak YK; Engelman DM
J Mol Biol; 2011 Oct; 413(2):359-71. PubMed ID: 21888917
[TBL] [Abstract][Full Text] [Related]
9. Tuning a polar molecule for selective cytoplasmic delivery by a pH (Low) insertion peptide.
Wijesinghe D; Engelman DM; Andreev OA; Reshetnyak YK
Biochemistry; 2011 Nov; 50(47):10215-22. PubMed ID: 22029270
[TBL] [Abstract][Full Text] [Related]
10. pHLIP-mediated translocation of membrane-impermeable molecules into cells.
Thévenin D; An M; Engelman DM
Chem Biol; 2009 Jul; 16(7):754-62. PubMed ID: 19635412
[TBL] [Abstract][Full Text] [Related]
11. Bilayer Thickness and Curvature Influence Binding and Insertion of a pHLIP Peptide.
Karabadzhak AG; Weerakkody D; Deacon J; Andreev OA; Reshetnyak YK; Engelman DM
Biophys J; 2018 May; 114(9):2107-2115. PubMed ID: 29742404
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of pHLIP peptide insertion into and exit from a membrane.
Slaybaugh G; Weerakkody D; Engelman DM; Andreev OA; Reshetnyak YK
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12095-12100. PubMed ID: 32409607
[TBL] [Abstract][Full Text] [Related]
13. pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.
Yu M; Chen Y; Wang Z; Ding X
Breast Cancer Res Treat; 2020 Apr; 180(2):379-384. PubMed ID: 32034579
[TBL] [Abstract][Full Text] [Related]
14. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.
Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q
Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477
[TBL] [Abstract][Full Text] [Related]
15. pH-Dependent Transmembrane Activity of Peptide-Functionalized Gold Nanostars for Computed Tomography/Photoacoustic Imaging and Photothermal Therapy.
Tian Y; Zhang Y; Teng Z; Tian W; Luo S; Kong X; Su X; Tang Y; Wang S; Lu G
ACS Appl Mater Interfaces; 2017 Jan; 9(3):2114-2122. PubMed ID: 28058834
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.
Burns KE; Robinson MK; Thévenin D
Mol Pharm; 2015 Apr; 12(4):1250-8. PubMed ID: 25741818
[TBL] [Abstract][Full Text] [Related]
17. Determination of the Membrane Translocation pK of the pH-Low Insertion Peptide.
Scott HL; Westerfield JM; Barrera FN
Biophys J; 2017 Aug; 113(4):869-879. PubMed ID: 28834723
[TBL] [Abstract][Full Text] [Related]
18. Tuning the insertion properties of pHLIP.
Musial-Siwek M; Karabadzhak A; Andreev OA; Reshetnyak YK; Engelman DM
Biochim Biophys Acta; 2010 Jun; 1798(6):1041-6. PubMed ID: 19766589
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment.
Cheng CJ; Bahal R; Babar IA; Pincus Z; Barrera F; Liu C; Svoronos A; Braddock DT; Glazer PM; Engelman DM; Saltzman WM; Slack FJ
Nature; 2015 Feb; 518(7537):107-10. PubMed ID: 25409146
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
